Hemarina

Recent coverage of Hemarina has focused on the therapeutic applications of sea worm blood derived from Brittany lugworms, with reports highlighting its use in treating burn victims and potential medical applications. The company has also faced scrutiny from sports authorities concerned about the possible misuse of its blood-derived products by athletes, generating debate about whether such applications pose doping risks in competitive sports.

Summarized from the headlines in the sidebar; see each source for the full story.